Literature Search and Pre-formulation Studies
Research & Development
- Home
- Research & Development
Research Formulation
Advancing Science, Delivering Care
At HAB Pharma, research and development is focused on translating pharmaceutical science into safe, effective and patient-focused medicines. Our formulation R&D combines scientific expertise, structured development processes and an understanding of drug delivery to develop formulations designed for quality, stability and consistent performance.
From selecting suitable formulations and excipients to optimisation, analytical evaluation and stability testing, we follow a systematic approach to developing robust, scalable dosage forms. Each stage focuses on reproducibility, manufacturability and reliable performance throughout the product lifecycle.
With capabilities spanning conventional, complex and specialised formulations, HAB Pharma takes products from concept through development and towards commercialisation, supporting the progression from scientific research to market-ready medicines.
R&D That Turns Science Into Solutions
Our multidisciplinary R&D framework brings together the expertise needed to support pharmaceutical development at every stage.
Formulation Development and Technology Transfer
Development of robust formulations and support for their transfer to manufacturing.
Analytical Method Development
Establishment and validation of analytical methods to assess product quality.
Compliance and Quality Assurance
Maintaining adherence to quality standards throughout the development process.
Intellectual Property Management
Supporting innovation through structured intellectual property strategies.
Regulatory Affairs
Aligning product development with regulatory requirements to support the approval process.
Project Management
Coordinating cross-functional activities to support timely and efficient execution.
Quality Control
Quality control is an important part of the process, from manufacturing through to final product delivery. We assess potential interactions that may affect product quality and undertake relevant checks on packaging materials.
Where applicable, testing includes evaluating whether a preparation is adsorbed onto plastic surfaces and whether plasticisers, lubricants, pigments or stabilisers may leach from plastic packaging into the preparation.
We also assess the quality of adhesives used for packaging labels as part of our quality checks.
Our Process
From Concept to Commercialization
01
02
03
04
05
06
07
08
Formulation & Dosage Expertise
Our R&D capabilities span a range of dosage forms, allowing us to address diverse therapeutic and drug-delivery requirements across product categories.
Dosage Form Capabilities
- Solid Oral Dosage Forms: Tablets, capsules, pellets
- Liquid Dosage Forms: Solutions and suspensions
- Semi-Solid Dosage Forms: Creams, gels, ointments and emulsions
- Injectable Dosage Forms: Solution injections, lyophilised injections and dry powder injections.
- Ophthalmic Dosage Forms: Eye drops and eye suspensions
Advanced & Complex
Formulation Expertise
Alongside conventional dosage forms, we have capabilities in developing complex and specialised formulations for differentiated pharmaceutical products.
Our expertise includes:
- Modified, extended and delayed-release formulations
- Enteric-coated dosage forms
- Multi-Unit Pelletisation Systems (MUPS)
- Nanosuspensions
- Formulations for oncology, hormonal and potent molecules
Quality by Design in R&D
Quality by Design (QbD) principles guide our formulation development process. Rather than assessing quality only at the end, we incorporate quality considerations from the beginning.
We combine active pharmaceutical ingredients with suitable excipients and conduct structured laboratory-scale trials to evaluate and optimise formulations. This approach supports reproducibility and helps prepare formulations for manufacturing.
By integrating quality considerations throughout development, we focus on consistency, process control and the transition from laboratory prototypes to commercial-scale production.
Quality Built Into Every Stage
At HAB Pharma, quality is an integral part of the R&D lifecycle. From early-stage development and analytical evaluation to documentation and technology transfer, we follow defined protocols, maintain data integrity and conduct structured technical reviews to support consistency, reliability and compliance.
Our quality framework includes stage-wise technical and peer reviews, analytical method validation, comprehensive documentation, and routine equipment calibration and validation.
These measures help identify and address potential deviations early, supporting product robustness before technology transfer to manufacturing. By integrating quality into development from the outset, we establish a foundation for scientific rigour, process discipline and scale-up.
Therapeutic Areas
Our formulation capabilities span a range of therapeutic areas, supporting diverse healthcare needs through pharmaceutical development.
Analgesics
Formulations for the management of back, joint and inflammatory pain.
Cardio Vascular
Products addressing heart health, blood pressure control and cholesterol management.
Central Nervous System
Formulations supporting neurological health, sleep-related conditions and mental wellness.
Digestive System
Products addressing acidity, gut health and gastrointestinal conditions.
Endocrine & Diabetes
Formulations for metabolic disorders and blood glucose management.
Respiratory System
Products for asthma, nasal congestion and other pulmonary conditions.
Infections
Antibiotics, antifungals and other anti-infective products for bacterial and fungal infections.
Skin & Hair
Dermatological formulations, including serums, creams and specialised hair-care products.
Nutrition
Vitamins, minerals and dietary supplements to support nutritional needs and overall wellbeing.
Reproductive & Urinary
Products addressing reproductive health and urological conditions.
Protecting Innovation & Intellectual Property
Intellectual property management is an integral part of our product development framework. We follow a structured approach to identifying, evaluating, protecting and monitoring intellectual property throughout the development lifecycle, with a focus on safeguarding formulation know-how, process innovation and other proprietary assets.
Novel formulation and composition approaches
Novel combinations and applications
Innovative or functional processes
Unique processing parameters
Product and brand concepts
Patent applications for eligible technologies, formulations and processes
Patent clearance and landscape analysis
Freedom-to-Operate (FTO) assessments at appropriate stages of development
Protection of confidential manufacturing know-how and technical information
Appropriate registration and protection of trademarks and other applicable intellectual property rights
Confidentiality & Information Protection
We follow defined confidentiality protocols and use Non-Disclosure Agreements (NDAs) with relevant employees, contractors, customers, vendors, suppliers and external partners.
Access to sensitive technical and commercial information is appropriately controlled to help safeguard formulation information, manufacturing processes, development data and other proprietary assets.
IP Monitoring & Governance
We monitor intellectual property assets and relevant third-party developments as part of our broader IP governance framework. Where appropriate, we take suitable measures to protect the Company's intellectual property rights and proprietary information against unauthorised use or potential infringement.
By integrating intellectual property considerations into product development, we aim to protect proprietary knowledge while supporting continued innovation.
R&D That Turns Science Into Solutions
Our multidisciplinary R&D framework encompasses:
Formulation Development & Technology Transfer
Development of robust formulations and seamless transfer to manufacturing.
Analytical Methods
Development
Establishment and validation of analytical methods to ensure product quality.
Compliance Quality Assurance
Ensuring adherence to quality standards across all development stages.
Intellectual Property Management
Supporting innovation through structured IP strategies.
Regulatory Affairs
Aligning development with regulatory requirements for successful approvals.
Project Management
Coordinating cross-functional activities for timely and efficient execution.
- A-301, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel (West), Mumbai – 400013.
- info@habpharma.in
- 022-66261400